Natural Capsules Limited will hold its 33rd Annual General Meeting (AGM) on Wednesday, August 12, 2026, at 12:00 PM IST via video conferencing. Shareholders holding shares on the record date of August 5, 2026, are eligible to participate and vote. The meeting will be conducted through Video Conference (VC) or Other Audio Visual Means (OAVM) without physical presence, complying with Ministry of Corporate Affairs guidelines.

The AGM agenda includes the adoption of audited financial statements for the financial year ended March 31, 2026, and the re-appointment of directors Mrs. Jyoti Mundra and Mr. Laxminarayan Moondra. Shareholders will also vote on the re-appointment of Mr. Laxminarayana Moondra as Whole time Director for a term of 3 years effective August 20, 2026, with a revised remuneration package. The Board has proposed a monthly salary of ₹ 3,20,000 on a scale of ₹ 3,20,000-20,000-3,60,000, along with perquisites such as a car with driver, medical reimbursement, and Leave Travel Concession.

Special business includes approving related party transactions with subsidiary Natural Biogenex Private Limited. The company seeks approval to enter into contracts and provide unsecured loans up to ₹ 50 crores until the conclusion of the next AGM. Additionally, shareholders will consider revising the remuneration of Mr. Shrey Mundra, General Manager – Marketing, a related party. His gross remuneration is proposed to increase from ₹ 2,25,000 to ₹ 2,50,000 per month from April 1, 2026, and to ₹ 2,75,000 per month thereafter for one year.

Remote e-voting will commence on August 8, 2026, at 09:00 AM and conclude on August 11, 2026, at 05:00 PM. Members can cast votes electronically through the NSDL e-voting system. Those attending the AGM via VC/OAVM can also vote during the meeting if they have not voted remotely. The facility is available on a first-come-first-served basis for 1,000 members, excluding large shareholders and institutional investors.

Key AGM Dates

Natural Biogenex Private Limited, a material unlisted subsidiary of natural capsules , has allotted 1,11,202 equity shares of ₹10 each for cash at par. The allotment aggregates to ₹11,12,020 and was approved by the board of the subsidiary on July 10, 2026. The rights issue was previously approved by the board on May 27, 2026.

Allotment Details

The board of Natural Biogenex Private Limited approved the allotment of the rights issue shares during its meeting held on July 10, 2026. The shares were issued for cash at par, with the total amount aggregating to ₹11,12,020.

The intimation regarding the allotment was submitted to BSE Limited and National Stock Exchange of India Limited under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.